Kirkland & Ellis advised Oakley Capital on the transaction.Oakley Capital announced the acquisition of a majority stake in vitroconnect. Oakley Capital is investing alongside vitroconnect founder…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
